[Federal Register Volume 62, Number 120 (Monday, June 23, 1997)]
[Notices]
[Pages 33875-33876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-16322]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-97-13]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Wilma Johnson, CDC
Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA
30333. Written comments should be received within 60 days of this
notice.
Proposed Projects
1. Endometriosis and Exposure to Endocrine Disrupting Compounds--
New--Exposure to endocrine disrupting compounds (determined by the
concentration of these compounds and their metabolites in serum) may be
associated with the incidence of endometriosis. Over two years, a case-
control study will be conducted to compare serum levels of PCB's,
pesticides, and dioxins in 50 women with newly diagnosed,
laproscopically-confirmed endometriosis with serum levels in 50 women
who are presumed free of endometriosis. Information on risk factors for
endometriosis which may confound the association between endocrine
disruptors and endometriosis will be obtained. These factors include
demographics, smoking, and reproductive history. Information on
potential sources of exposure to endocrine disrupting compounds (e.g.,
[[Page 33876]]
tampons and occupational or personal use of pesticides and herbicides)
will also be obtained. The total cost to respondents is $ 0 .
----------------------------------------------------------------------------------------------------------------
No. of Avg. burden/
Respondents No. of responses/ response (in Total burden
respondents respondent hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Women........................................... 100 1 .50 50
---------------------------------------------------------------
Total....................................... .............. .............. .............. 50
----------------------------------------------------------------------------------------------------------------
2. (NIOSH) Occupational Asthma Identification Methods -0920-0350--
Extension--Over the last decade, OCCUPATIONAL ASTHMA (OA) has emerged
as the most prevalent occupational respiratory disease, resulting in
morbidity, disability, diminished productivity, and rarely, death.
Prevention of OA has become one of the most important goals for NIOSH.
This project addresses these issues by examining the potential of
different asthma screening approaches as surveillance tools when
employed serially over time among workers at risk, and also
characterizes the occurrence of and risk factors for occupational
asthma in various high risk industries.
The primary objective of the study is to examine the potential of
different asthma screening approaches as surveillance tools when
employed serially over time among workers at risk. A second major
objective is to characterize the occurrence of and risk factors for
occupational asthma in several industries, specifically workers rearing
insects for agricultural pest control, wood product workers using
isocyanates, and other occupational groups with different exposure
profiles.
A series of four groups of screening measures are applied to
examine the potential of each measure in different situations. This
includes a questionnaire (including an occupational history), lung
function tests (shift spirometry, serial peak flow tests, airway
responsiveness), inflammation and immunology tests (specific and
nonspecific serum immunoglobulins, skin prick tests, nasal lavage for
cellular and biochemical factors), and environmental measurements
(gravimetric dusts, antigens, chemical vapors, viable organisms,
endotoxins). Workers exposed to (1) high molecular weight sensitizing
dusts, (insect particulate), (2) low molecular weight sensitizers,
(methylene biphenyldiisocyanate, MDI), and (3) irritant but not
sensitizing exposures, as well as a control group of unexposed workers,
are followed for two years.
The results should be useful in improving tools for recognition,
monitoring, and surveillance of OA. In addition, risk factors for OA
will be further delineated, which will assist in targeting OA
prevention strategies for agricultural and other workers. The total
cost to respondents is $11,960.
----------------------------------------------------------------------------------------------------------------
No. of Avg. burden/
Respondents No. of responses/ response (in Total burden
respondents respondent hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Workers......................................... 299 2 2.0 1,196
---------------------------------------------------------------
Total....................................... .............. .............. .............. 1,196
----------------------------------------------------------------------------------------------------------------
Dated: June 13, 1997.
Wilma G. Johnson,
Acting Associate Director for Policy Planning And Evaluation, Centers
for Disease Control and Prevention (CDC) .
[FR Doc. 97-16322 Filed 6-20-97; 8:45 am]
BILLING CODE 4163-18-P
